November 28, 2024 - 20:29

As discussions around new tariffs gain momentum, consumers are advised to consider their purchases carefully. With the potential for tariffs to increase under the incoming administration, it is likely that prices for various goods will soon rise. History has shown that when tariffs are implemented, the cost of imported items typically escalates, impacting everything from electronics to everyday household products.
In light of this, individuals may want to prioritize purchasing certain items before these tariffs take effect. Essential goods, such as appliances, clothing, and consumer electronics, could see significant price hikes. Furthermore, buying durable goods now could save consumers money in the long run, as the added costs associated with tariffs could lead to higher retail prices.
As uncertainty looms over the economic landscape, being proactive in purchasing decisions may help mitigate the financial impact of impending tariffs. It’s an opportune moment for consumers to assess their needs and make informed buying choices.
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...